Clinical trial
Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients
NCT00494949 · Sangart, Industry · Completed
Key facts
| NCT number | NCT00494949 |
|---|---|
| Title | Increasing Dose Safety Study of Hemospan in Orthopedic Surgery Patients |
| Official title | A Clinical Safety (Phase Ib/II) Increasing Dose Study of MP4 (Hemospan) in Orthopedic Surgery Patients |
| Lead sponsor | Sangart, Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hypotension, Hypoxia |
| Intervention type | Drug |
| Interventions | Hemospan (MP4OX), Ringer's lactate |
| Enrollment | 30 |
| Start date | Apr 1, 2003 |
| Primary completion | Jul 1, 2006 |
| Completion | Aug 1, 2006 |
| First posted | Jul 2, 2007 |
| Last update posted | Aug 19, 2013 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: